VYNE Therapeutics Inc.
USD0.76
-0.01 (-0.85%)
CEO
David T. Domzalski
IPO Date
2018-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.76
Prev. Close
$0.77
Day Low
$0.74
Day High
$0.78
52W Low
$0.28
52W High
$1.59
Market Cap
$0.01B
Volume
0.98M
| 2,370 |
| $0.65 |
| 2 Jul 2026 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F-InKind | Disposed | 3,464 | $0.65 |
| 2 Jul 2026 | Domzalski David | director, officer: PRESIDENT AND CEO | F-InKind | Disposed | 12,214 | $0.65 |
| 2 Jun 2026 | Domzalski David | director, officer: PRESIDENT AND CEO | A-Award | Acquired | 30,791 | $0.31 |
| 2 Apr 2026 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F-InKind | Disposed | 4,007 | $0.60 |
| 2 Apr 2026 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F-InKind | Disposed | 2,876 | $0.60 |
| 2 Apr 2026 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F-InKind | Disposed | 4,007 | $0.60 |
| 2 Apr 2026 | Domzalski David | director, officer: PRESIDENT AND CEO | F-InKind | Disposed | 14,232 | $0.60 |
| 5 Jan 2026 | Domzalski David | director, officer: PRESIDENT AND CEO | F-InKind | Disposed | 12,684 | $0.58 |